Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI could help heart surgery patients get the right Anti-Inflammatory drug

NCT ID NCT07583290

Ongoing Knowledge-focused Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze data from 10,000 patients across four heart centers in China to build and test the AI tool. The goal is to personalize treatment and improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ulinastatin

What this could lead to

If successful, this could help doctors personalize anti-inflammatory treatment for heart surgery patients, potentially reducing complications.

What could go wrong

This is an observational study, not a controlled trial, so it cannot prove cause and effect. The AI tool needs further validation before it can be used in practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic disorder congenital heart disease coronary artery disorder heart valve disorder multiple organ dysfunction syndrome Postoperative Complications Systemic Inflammatory Response Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGICAL PROCEDURES CARDIOPULMONARY BYPASS MULTIPLE ORGAN DYSFUNCTION SYNDROME POSTOPERATIVE COMPLICATIONS SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Contacts and locations

Locations

  • Center for Cardiac Surgery and Critical Care

    Beijing, China